Article Listing - Shock French price cuts for effective drugs "will cost industry $116

GLOOMY 1st QTR RESULTS AT HOECHST

4 May 1992

The German chemical and pharmaceutical group Hoechst has announced declines in profit for the first quarter of 1992. Pretax profit...

Immunomedics' Immuno-RAID-LL2

4 May 1992

Immunomedics' Immuno-RAID-LL2 lymphoma imaging agent has been granted orphan dru

HYPOLIPEMIC RESEARCH IN JAPAN

4 May 1992

Scientists at the Institute of Physical and Chemical Res-earch in Saitama, Japan, are investigating the compound 4-cholesten-3-one for its...

ROMANIAN DRUG INDUSTRY MOVES

4 May 1992

The Romanian Ministries of Health and Industry have, with funding from the World Bank, awarded PA Consulting Group a contract...

RUSSIA PLANS HEALTH INSURANCE

4 May 1992

The republic of Russia is planning to introduce a system of compulsory health insurance for all its 157 million people,...

US PANEL CALLS FOR PROPULSID APPROVAL

4 May 1992

The US Food and Drug Administra-tion's gastrointestinal drugs advis-ory committee has unanimously recommended that Janssen's gastric motility agent Propulsid (cisapride)...

RETROVIR TO VIDEX SWITCH BENEFIT

4 May 1992

Switching HIV-infected patients who have received treatment with Wellcome's Retrovir (zidovudine) for over 16 weeks over to Bristol-Myers Squibb's Videx...